• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病在绝经前、绝经后和多囊卵巢综合征妇女中的流行情况。雌激素的作用。

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

机构信息

Medica Sur Clinic and Foundation, Mexico City, Mexico.

出版信息

Ann Hepatol. 2010 Oct-Dec;9(4):402-9.

PMID:21057159
Abstract

BACKGROUND & AIM: Non alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. Population studies have demonstrated that men and posmenopausal women have higher prevalence of NAFLD. The aim was to investigate the prevalence of NAFLD in premenopausal, posmenopausal and polycystic ovary syndrome (PCOS) women.

METHODS

A cross sectional study carried out at University Hospital in Mexico City from January 2009 to November 2009. One hundred ninety seven women who agreed to participate were divided into groups, comprising 93 with NAFLD and without NAFLD. Anthropometric, metabolic and biochemical variables were measured. Serum estradiol and cortisol concentrations were determined and compared between the groups.

RESULTS

Of the 197 patients, 93(47.2%) had NAFLD and 104 (52.8%) did not have NAFLD. The prevalence of NAFLD in premenopausal, postmenopausal and PCOS patients was 32.2, 57.9, and 62%, respectively. Age, BMI, hip to waist ratio, fasting glucose, HOMA -IR, and insulin were significantly higher in NAFLD patients. Women without NAFLD had significantly higher levels of serum estradiol (100 ± 95.4) compared with NAFLD patients (55.5 ± 66.6) p = 0.001. By group with and without NAFLD: premenopausal (55.44±93.3 vs. 128.56 ± 109.22), posmenopausal (44.98 ± 51.41 vs. 42.72 ± 51.48) and PCOS women (64.9 ± 53.3 vs. 101.36 ± 80.89) had significantly different hormone profile.

CONCLUSION

These results suggest that NAFLD is more prevalent in postmenopausal and women with PCOS than those premenopausal ones. The estrogens may have a protective effect of against NAFLD in women.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)是西方国家最常见的肝脏疾病。人群研究表明,男性和绝经后女性的 NAFLD 患病率更高。本研究旨在调查绝经前、绝经后和多囊卵巢综合征(PCOS)妇女中 NAFLD 的患病率。

方法

这是一项 2009 年 1 月至 11 月在墨西哥城大学医院进行的横断面研究。共纳入 197 名同意参与的女性,分为有和无 NAFLD 两组。测量了人体测量学、代谢和生化变量。检测并比较了两组患者的血清雌二醇和皮质醇浓度。

结果

197 名患者中,93 名(47.2%)患有 NAFLD,104 名(52.8%)无 NAFLD。绝经前、绝经后和 PCOS 患者的 NAFLD 患病率分别为 32.2%、57.9%和 62%。NAFLD 患者的年龄、BMI、腰臀比、空腹血糖、HOMA-IR 和胰岛素均显著升高。无 NAFLD 的女性血清雌二醇水平显著高于 NAFLD 患者[(100±95.4)pg/ml 比(55.5±66.6)pg/ml,p=0.001]。按有无 NAFLD 分组:绝经前(55.44±93.3 比 128.56±109.22)、绝经后(44.98±51.41 比 42.72±51.48)和 PCOS 患者(64.9±53.3 比 101.36±80.89)的激素谱有显著差异。

结论

这些结果表明,绝经后和 PCOS 女性的 NAFLD 患病率高于绝经前女性。雌激素可能对女性的 NAFLD 具有保护作用。

相似文献

1
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.非酒精性脂肪性肝病在绝经前、绝经后和多囊卵巢综合征妇女中的流行情况。雌激素的作用。
Ann Hepatol. 2010 Oct-Dec;9(4):402-9.
2
Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.非酒精性脂肪性肝病的绝经前妇女多囊卵巢综合征的患病率增加。
Eur J Endocrinol. 2015 Dec;173(6):739-47. doi: 10.1530/EJE-15-0567. Epub 2015 Sep 4.
3
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.多囊卵巢综合征女性中的非酒精性脂肪性肝病
J Hepatol. 2007 Sep;47(3):412-7. doi: 10.1016/j.jhep.2007.04.012. Epub 2007 May 24.
4
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.雄激素生物利用度增加与多囊卵巢综合征女性的非酒精性脂肪性肝病有关。
Hum Reprod. 2010 Jan;25(1):212-20. doi: 10.1093/humrep/dep380. Epub 2009 Nov 3.
5
Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.与其他女孩和男孩相比,患有非酒精性脂肪性肝病加多囊卵巢综合征的青春期女孩的不良代谢表型。
J Gastroenterol Hepatol. 2016 May;31(5):980-7. doi: 10.1111/jgh.13241.
6
Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.胰岛素抵抗和高雄激素血症可独立预测多囊卵巢综合征女性的非酒精性脂肪性肝病。
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1065-1069. doi: 10.1016/j.dsx.2018.12.020. Epub 2019 Jan 8.
7
Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.用于诊断绝经前女性多囊卵巢综合征伴或不伴非酒精性脂肪性肝病的内脏脂肪指数。
Maturitas. 2018 Oct;116:1-7. doi: 10.1016/j.maturitas.2018.06.013. Epub 2018 Jul 4.
8
Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.多囊卵巢综合征伴高雄激素血症是肥胖非酒精性脂肪性肝病的危险因素。
Aliment Pharmacol Ther. 2017 Jun;45(11):1403-1412. doi: 10.1111/apt.14058. Epub 2017 Mar 30.
9
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.衰老也是绝经前女性非酒精性脂肪性肝病的一个风险因素。
World J Gastroenterol. 2012 Jan 21;18(3):237-43. doi: 10.3748/wjg.v18.i3.237.
10
[Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].[中药化解法对多囊卵巢综合征伴非酒精性脂肪性肝病脂质代谢的影响]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jun;33(6):751-6.

引用本文的文献

1
The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity.甘油三酯-葡萄糖(TyG)指数及改良TyG指数预测肥胖儿童人群中代谢相关脂肪性肝病和代谢综合征的能力
J Clin Med. 2025 Mar 28;14(7):2341. doi: 10.3390/jcm14072341.
2
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021.2010年至2021年代谢功能障碍相关脂肪性肝病的全球负担
JHEP Rep. 2024 Nov 14;7(3):101271. doi: 10.1016/j.jhepr.2024.101271. eCollection 2025 Mar.
3
Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort.
儿童代谢功能障碍相关脂肪性肝病的潜在替代生物标志物和新型生物标志物:来自中国队列的探索性证据。
BMC Gastroenterol. 2025 Jan 22;25(1):28. doi: 10.1186/s12876-025-03619-2.
4
Hormone replacement therapy for steatotic liver management after surgical menopause.手术绝经后脂肪性肝病管理的激素替代疗法。
Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.
5
Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD.美国非酒精性脂肪性肝病(NAFLD)成人患者中浙江大学(ZJU)指数与肝脂肪变性及肝纤维化的相关性。
Front Med (Lausanne). 2024 Aug 15;11:1443811. doi: 10.3389/fmed.2024.1443811. eCollection 2024.
6
Sex hormones differently regulate lipid metabolism genes in primary human hepatocytes.性激素对原代人肝细胞中脂质代谢基因的调控作用不同。
BMC Endocr Disord. 2024 Aug 1;24(1):135. doi: 10.1186/s12902-024-01663-9.
7
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!非酒精性脂肪性肝病男性患者心血管死亡率过高:令人担忧!
World J Cardiol. 2024 Jul 26;16(7):380-384. doi: 10.4330/wjc.v16.i7.380.
8
The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study.《1990-2019 年西太平洋地区工作年龄人群非酒精性脂肪性肝病负担:全球疾病负担研究的年龄-时期-队列分析》。
BMC Public Health. 2024 Jul 11;24(1):1852. doi: 10.1186/s12889-024-19047-y.
9
The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease.绝经状态、胰岛素抵抗和体重指数对非酒精性脂肪性肝病患病率的影响。
Healthcare (Basel). 2024 May 24;12(11):1081. doi: 10.3390/healthcare12111081.
10
Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.代谢功能障碍相关脂肪性肝病、慢性肾脏病与腹型肥胖之间的关联:一项全国性回顾性队列研究。
Sci Rep. 2024 Jun 2;14(1):12645. doi: 10.1038/s41598-024-63386-0.